Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Phillips

Showing results (161-170 of 199) with videos related to

Pageof 20
Sort By:
Archives of Toxicology|September 5, 2020
Mutagenicity of acrylamide and glycidamide in human TP53 knock-in (Hupki) mouse embryo fibroblastsLisa Hölzl-Armstrong, Jill E Kucab, Sarah Moody, et al.
Occupational and Environmental Medicine|November 15, 2018
Bulky DNA adducts, microRNA profiles, and lipid biomarkers in Norwegian tunnel finishing workers occupationally exposed to diesel exhaustIselin Rynning, Volker M Arlt, Kristyna Vrbova, et al.
Carcinogenesis|January 20, 2004
Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemicalEilish T Donnelly, Helen Bardwell, Geraldine Anne Thomas, et al.
International Journal of Cancer|June 13, 2014
Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathyHeinz H Schmeiser, Jöelle L Nortier, Rajinder Singh, et al.
Cell|April 16, 2019
A Compendium of Mutational Signatures of Environmental AgentsJill E Kucab, Xueqing Zou, Sandro Morganella, et al.
Carcinogenesis|January 22, 2008
Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null miceVolker M Arlt, Marie Stiborová, Colin J Henderson, et al.
Mutagenesis|October 27, 2011
STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statementValentina Gallo, Matthias Egger, Valerie McCormack, et al.
European Journal of Clinical Investigation|October 26, 2011
STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statementValentina Gallo, Matthias Egger, Valerie McCormack, et al.
Preventive Medicine|October 28, 2011
STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statementValentina Gallo, Matthias Egger, Valerie McCormack, et al.
Annals of Internal Medicine|April 5, 2013
The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative reviewM Refik Gökmen, Jean-Pierre Cosyns, Volker M Arlt, et al.
Pageof 20

Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
Archives of Toxicology|September 5, 2020
Mutagenicity of acrylamide and glycidamide in human TP53 knock-in (Hupki) mouse embryo fibroblastsLisa Hölzl-Armstrong, Jill E Kucab, Sarah Moody, et al.
Occupational and Environmental Medicine|November 15, 2018
Bulky DNA adducts, microRNA profiles, and lipid biomarkers in Norwegian tunnel finishing workers occupationally exposed to diesel exhaustIselin Rynning, Volker M Arlt, Kristyna Vrbova, et al.
Carcinogenesis|January 20, 2004
Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemicalEilish T Donnelly, Helen Bardwell, Geraldine Anne Thomas, et al.
International Journal of Cancer|June 13, 2014
Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathyHeinz H Schmeiser, Jöelle L Nortier, Rajinder Singh, et al.
Cell|April 16, 2019
A Compendium of Mutational Signatures of Environmental AgentsJill E Kucab, Xueqing Zou, Sandro Morganella, et al.
Carcinogenesis|January 22, 2008
Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null miceVolker M Arlt, Marie Stiborová, Colin J Henderson, et al.
Mutagenesis|October 27, 2011
STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statementValentina Gallo, Matthias Egger, Valerie McCormack, et al.
European Journal of Clinical Investigation|October 26, 2011
STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statementValentina Gallo, Matthias Egger, Valerie McCormack, et al.
Preventive Medicine|October 28, 2011
STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statementValentina Gallo, Matthias Egger, Valerie McCormack, et al.
Annals of Internal Medicine|April 5, 2013
The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative reviewM Refik Gökmen, Jean-Pierre Cosyns, Volker M Arlt, et al.
Pageof 20